Cerebral ischemia: new risk factors

Area of Science:

• Neurology
• Cardiovascular Medicine
• Public Health

Background:

• Established modifiable risk factors (hypertension, smoking, diabetes, hyperlipidemia, atrial fibrillation) explain only half of cardiovascular disease risk.
• Identifying novel risk factors is crucial for comprehensive stroke prevention strategies.
• Cerebral atherosclerosis necessitates understanding beyond conventional risk factors.

Purpose of the Study:

• To review and highlight emerging risk factors for stroke, particularly in the context of cerebral atherosclerosis.
• To discuss the clinical significance and potential management of these new risk factors.
• To emphasize the importance of considering these factors in stroke patient evaluation and care.

Main Methods:

• Literature review and synthesis of current research on novel stroke risk factors.
• Focus on inflammatory markers, infections, homocysteine levels, and sleep-disordered breathing.
• Analysis of evidence regarding C-reactive protein, Chlamydia pneumoniae, homocysteine, and sleep apnea.

Main Results:

• Elevated C-reactive protein is a significant risk factor for heart disease and thromboembolic stroke.
• The role of Chlamydia pneumoniae in stroke remains debated.
• Influenza vaccination is a proven preventive measure against stroke.
• Homocysteine's clinical benefit from vitamin therapy requires further trial data.
• Sleep-disordered breathing is a potential risk factor with effective therapeutic options.

Conclusions:

• Inflammatory markers, infection, homocysteine, and sleep-disordered breathing are key emerging stroke risk factors.
• Neurologists should actively screen stroke patients for sleep disorders and consider early intervention with breathing therapy.
• Further research is needed to clarify the role of certain factors like Chlamydia pneumoniae and the benefits of homocysteine reduction therapies.